(R)-noradrenaline multiple interactions EXP 6480464 [cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] which results in decreased susceptibility to Norepinephrine CTD PMID:15834289 (S)-nicotine decreases expression ISO RGD:737537 6480464 Nicotine results in decreased expression of EDNRA mRNA CTD PMID:18247414 1,2-dimethylhydrazine multiple interactions ISO RGD:737538 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EDNRA mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:737538 6480464 1, 2-Dimethylhydrazine results in increased expression of EDNRA mRNA CTD PMID:22206623 11-deoxycorticosterone multiple interactions EXP 6480464 [5-(dimethylamino)-N-(3 more ... CTD PMID:16271043 , PMID:22431579 11-deoxycorticosterone affects response to substance EXP 6480464 EDNRA protein affects the susceptibility to Desoxycorticosterone CTD PMID:12600921 17beta-estradiol increases expression ISO RGD:737537 6480464 Estradiol results in increased expression of EDNRA mRNA CTD PMID:19943105 17beta-estradiol multiple interactions ISO RGD:737537 6480464 Tamoxifen inhibits the reaction [Estradiol results in increased expression of EDNRA mRNA] CTD PMID:19943105 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737538 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EDNRA mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of EDNRA mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EDNRA mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737538 6480464 Tetrachlorodibenzodioxin results in decreased expression of EDNRA mRNA CTD PMID:26290441 2-naphthylamine decreases expression ISO RGD:737537 6480464 2-Naphthylamine results in decreased expression of EDNRA mRNA CTD PMID:18247414 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression EXP 6480464 Puromycin Aminonucleoside results in increased expression of EDNRA mRNA CTD PMID:12972712 4,4'-sulfonyldiphenol increases expression ISO RGD:737538 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of EDNRA mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO RGD:737537 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of EDNRA gene CTD PMID:31601247 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide multiple interactions EXP 6480464 [5-(dimethylamino)-N-(3 more ... CTD PMID:16271043 5-fluorouracil affects response to substance ISO RGD:737537 6480464 EDNRA protein affects the susceptibility to Fluorouracil CTD PMID:17032313 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of EDNRA mRNA CTD PMID:24780913 , PMID:25825206 acadesine multiple interactions EXP 6480464 acadesine inhibits the reaction [Smoke results in increased expression of EDNRA protein] CTD PMID:36183783 acetamide increases expression EXP 6480464 acetamide results in increased expression of EDNRA mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:737537 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EDNRA mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EDNRA mRNA CTD PMID:32699268 actinomycin D multiple interactions EXP 6480464 [Dimethyl Sulfoxide co-treated with Dactinomycin] results in decreased expression of EDNRA mRNA more ... CTD PMID:20561571 aflatoxin B1 decreases methylation ISO RGD:737537 6480464 Aflatoxin B1 results in decreased methylation of EDNRA gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:737537 6480464 Aflatoxin B1 results in increased expression of EDNRA mRNA CTD PMID:32234424 aflatoxin B1 increases methylation ISO RGD:737537 6480464 Aflatoxin B1 results in increased methylation of EDNRA exon CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:737537 6480464 aflatoxin B2 results in increased methylation of EDNRA exon, aflatoxin B2 results in increased methylation of EDNRA intron CTD PMID:30157460 agmatine multiple interactions ISO RGD:737537 6480464 Agmatine inhibits the reaction [Palmitic Acid results in decreased expression of EDNRA protein] CTD PMID:35747990 aldehydo-D-glucose increases expression ISO RGD:737537 6480464 Glucose results in increased expression of EDNRA mRNA CTD PMID:31655124 aldosterone multiple interactions EXP 6480464 [cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA], [EDN1 protein binds to and results in increased activity of EDNRA protein] promotes the reaction [Aldosterone results in increased expression of IL18 mRNA] CTD PMID:18660453 all-trans-retinoic acid increases expression ISO RGD:737537 6480464 Tretinoin results in increased expression of EDNRA mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions ISO RGD:737538 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of EDNRA mRNA CTD PMID:30951980 all-trans-retinoic acid decreases expression ISO RGD:737537 6480464 Tretinoin results in decreased expression of EDNRA mRNA CTD PMID:23724009 alpha-pinene multiple interactions ISO RGD:737537 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EDNRA mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EDNRA mRNA CTD PMID:32699268 ambrisentan multiple interactions ISO RGD:737537 6480464 ambrisentan binds to and results in decreased activity of EDNRA protein CTD PMID:16219361 aminoguanidine multiple interactions EXP 6480464 pimagedine inhibits the reaction [Isoproterenol results in increased expression of EDNRA mRNA] CTD PMID:18594475 amitrole increases expression EXP 6480464 Amitrole results in increased expression of EDNRA mRNA CTD PMID:30047161 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Particulate Matter results in increased expression of EDNRA mRNA], pyrazolanthrone inhibits the reaction [Particulate Matter results in increased expression of EDNRA protein] CTD PMID:20561571 antirheumatic drug increases expression ISO RGD:737537 6480464 Antirheumatic Agents results in increased expression of EDNRA mRNA CTD PMID:24449571 apocynin multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA mRNA], acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA protein] CTD PMID:23270704 arsane affects expression ISO RGD:737538 6480464 Arsenic affects the expression of EDNRA mRNA CTD PMID:19654921 arsenic atom affects expression ISO RGD:737538 6480464 Arsenic affects the expression of EDNRA mRNA CTD PMID:19654921 aspartame decreases expression ISO RGD:737537 6480464 Aspartame results in decreased expression of EDNRA mRNA CTD PMID:31655124 atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin promotes the reaction [Losartan results in decreased expression of EDNRA mRNA], Losartan promotes the reaction [Atorvastatin results in decreased expression of EDNRA mRNA] CTD PMID:23091284 atorvastatin calcium decreases expression EXP 6480464 Atorvastatin results in decreased expression of EDNRA mRNA CTD PMID:23091284 atrasentan multiple interactions ISO RGD:737538 6480464 atrasentan binds to and results in decreased activity of EDNRA protein CTD PMID:18516094 atrasentan multiple interactions EXP 6480464 Atrasentan inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of EDNRA mRNA] CTD PMID:34102242 atrasentan multiple interactions ISO RGD:737537 6480464 atrasentan binds to and results in decreased activity of EDNRA protein CTD PMID:12193141 more ... atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of EDNRA mRNA CTD PMID:36841081 belinostat increases expression ISO RGD:737537 6480464 belinostat results in increased expression of EDNRA mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:737537 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRA mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:737537 6480464 Benzo(a)pyrene results in decreased expression of EDNRA mRNA CTD PMID:18247414 benzo[a]pyrene increases methylation ISO RGD:737537 6480464 Benzo(a)pyrene results in increased methylation of EDNRA promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:737538 6480464 Benzo(a)pyrene results in decreased expression of EDNRA mRNA CTD PMID:22228805 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of EDNRA mRNA CTD PMID:20920545 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:737537 6480464 Diethylhexyl Phthalate results in decreased expression of EDNRA mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:737538 6480464 bisphenol A results in increased expression of EDNRA mRNA CTD PMID:26063408 , PMID:30951980 bisphenol A decreases expression ISO RGD:737538 6480464 bisphenol A results in decreased expression of EDNRA mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO RGD:737538 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of EDNRA mRNA CTD PMID:30951980 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of EDNRA mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:737538 6480464 bisphenol F results in increased expression of EDNRA mRNA CTD PMID:30951980 bosentan multiple interactions ISO RGD:737537 6480464 bosentan binds to and results in decreased activity of EDNRA protein CTD PMID:16219361 bosentan multiple interactions EXP 6480464 3 more ... CTD PMID:11093786 , PMID:15964565 BQ 123 multiple interactions EXP 6480464 3 more ... CTD PMID:11093786 more ... BQ 123 decreases activity ISO RGD:737537 6480464 cyclo(Trp-Asp-Pro-Val-Leu) results in decreased activity of EDNRA protein CTD PMID:18813882 BQ 123 multiple interactions ISO RGD:737538 6480464 cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein CTD PMID:15072961 BQ 123 multiple interactions ISO RGD:737537 6480464 cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein CTD PMID:11535565 BQ 485 multiple interactions EXP 6480464 [BQ 485 binds to and results in decreased activity of EDNRA protein] which results in decreased expression of BCL2 protein CTD PMID:14736733 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of EDNRA mRNA CTD PMID:33453195 calcium atom affects activity EXP 6480464 Calcium affects the activity of EDNRA protein CTD PMID:12628492 calcium(0) affects activity EXP 6480464 Calcium affects the activity of EDNRA protein CTD PMID:12628492 cantharidin decreases expression ISO RGD:737538 6480464 Cantharidin results in decreased expression of EDNRA mRNA CTD PMID:36907384 carbon nanotube increases expression ISO RGD:737537 6480464 Nanotubes, Carbon results in increased expression of EDNRA mRNA CTD PMID:25511174 carbon nanotube decreases expression ISO RGD:737538 6480464 Nanotubes, Carbon analog results in decreased expression of EDNRA mRNA CTD PMID:25620056 carmustine affects response to substance ISO RGD:737537 6480464 EDNRA mRNA affects the susceptibility to Carmustine CTD PMID:16365179 celecoxib multiple interactions EXP 6480464 Celecoxib inhibits the reaction [Cyclosporine results in increased expression of EDNRA protein] CTD PMID:25656942 chromium(6+) affects expression ISO RGD:737538 6480464 chromium hexavalent ion affects the expression of EDNRA mRNA CTD PMID:28472532 cisplatin affects response to substance ISO RGD:737537 6480464 EDNRA protein affects the susceptibility to Cisplatin CTD PMID:17032313 cocaine increases expression ISO RGD:737537 6480464 Cocaine results in increased expression of EDNRA protein CTD PMID:18813882 cocaine increases expression EXP 6480464 Cocaine results in increased expression of EDNRA protein CTD PMID:17420087 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of EDNRA mRNA CTD PMID:27523638 cycloheximide multiple interactions EXP 6480464 [Dimethyl Sulfoxide co-treated with Cycloheximide] results in decreased expression of EDNRA mRNA more ... CTD PMID:20561571 cyclosporin A multiple interactions EXP 6480464 celecoxib inhibits the reaction [Cyclosporine results in increased expression of EDNRA protein] CTD PMID:25656942 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of EDNRA protein CTD PMID:25656942 D-glucose increases expression ISO RGD:737537 6480464 Glucose results in increased expression of EDNRA mRNA CTD PMID:31655124 daunorubicin increases expression EXP 6480464 Daunorubicin results in increased expression of EDNRA protein CTD PMID:20888384 daunorubicin multiple interactions EXP 6480464 telmisartan inhibits the reaction [Daunorubicin results in increased expression of EDNRA protein] CTD PMID:20888384 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of EDNRA mRNA CTD PMID:23640034 Deoxycorticosterone acetate multiple interactions EXP 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDNRA mRNA, [Ozone co-treated with Oxygen] inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDNRA mRNA] CTD PMID:26550192 dexamethasone decreases expression ISO RGD:737538 6480464 Dexamethasone results in decreased expression of EDNRA mRNA CTD PMID:22733784 dextran sulfate multiple interactions ISO RGD:737538 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EDNRA mRNA CTD PMID:29950665 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of EDNRA mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:737538 6480464 Dibutyl Phthalate results in increased expression of EDNRA mRNA CTD PMID:17361019 diethyl malate affects expression ISO RGD:737538 6480464 diethyl malate affects the expression of EDNRA mRNA CTD PMID:24814887 dimethyl sulfoxide multiple interactions EXP 6480464 [Dimethyl Sulfoxide co-treated with Cycloheximide] results in decreased expression of EDNRA mRNA more ... CTD PMID:20561571 dioxygen increases expression ISO RGD:737538 6480464 Oxygen deficiency results in increased expression of EDNRA mRNA more ... CTD PMID:21926265 , PMID:25203536 dioxygen multiple interactions EXP 6480464 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA mRNA] more ... CTD PMID:23270704 more ... dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of EDNRA mRNA, Oxygen deficiency results in increased expression of EDNRA protein CTD PMID:23270704 more ... dioxygen multiple interactions ISO RGD:737538 6480464 rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA mRNA], rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA protein] CTD PMID:21926265 disodium selenite multiple interactions ISO RGD:737538 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of EDNRA mRNA CTD PMID:23274088 dorsomorphin multiple interactions ISO RGD:737537 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions EXP 6480464 [cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] affects the reaction [Doxorubicin results in increased activity of CASP3 protein] CTD PMID:14736733 doxorubicin decreases expression ISO RGD:737537 6480464 Doxorubicin results in decreased expression of EDNRA mRNA CTD PMID:28940058 , PMID:29803840 elemental selenium multiple interactions ISO RGD:737537 6480464 [Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA CTD PMID:19244175 elemental selenium decreases expression ISO RGD:737537 6480464 Selenium results in decreased expression of EDNRA mRNA CTD PMID:19244175 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of EDNRA mRNA CTD PMID:29391264 enrasentan multiple interactions ISO RGD:737537 6480464 enrasentan binds to and results in decreased activity of EDNRA protein CTD PMID:16219361 ethanol increases expression ISO RGD:737538 6480464 Ethanol results in increased expression of EDNRA mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:737538 6480464 Ethanol affects the expression of EDNRA mRNA CTD PMID:30319688 fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of EDNRA mRNA CTD PMID:30307764 fluvastatin decreases expression EXP 6480464 fluvastatin results in decreased expression of EDNRA mRNA CTD PMID:28951255 folic acid multiple interactions ISO RGD:737538 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EDNRA mRNA CTD PMID:22206623 fructose multiple interactions EXP 6480464 KLK1 protein inhibits the reaction [Fructose results in increased expression of EDNRA mRNA] CTD PMID:14568997 fructose increases expression ISO RGD:737537 6480464 Fructose results in increased expression of EDNRA mRNA CTD PMID:31655124 fructose increases expression EXP 6480464 Fructose results in increased expression of EDNRA mRNA CTD PMID:14568997 , PMID:9869011 fulvestrant multiple interactions ISO RGD:737537 6480464 [fulvestrant co-treated with Tamoxifen co-treated with ZD4054] results in decreased expression of EDNRA mRNA CTD PMID:19943105 fulvestrant increases methylation ISO RGD:737537 6480464 Fulvestrant results in increased methylation of EDNRA gene CTD PMID:31601247 furan decreases expression EXP 6480464 furan results in decreased expression of EDNRA mRNA CTD PMID:25539665 furan increases expression EXP 6480464 furan results in increased expression of EDNRA mRNA CTD PMID:27387713 glucose increases expression ISO RGD:737537 6480464 Glucose results in increased expression of EDNRA mRNA CTD PMID:31655124 hexadecanoic acid multiple interactions ISO RGD:737537 6480464 Agmatine inhibits the reaction [Palmitic Acid results in decreased expression of EDNRA protein] CTD PMID:35747990 hexadecanoic acid decreases expression ISO RGD:737537 6480464 Palmitic Acid results in decreased expression of EDNRA protein CTD PMID:35747990 hydrogen cyanide decreases expression ISO RGD:737538 6480464 Hydrogen Cyanide results in decreased expression of EDNRA mRNA CTD PMID:33914522 inulin multiple interactions ISO RGD:737538 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of EDNRA mRNA CTD PMID:36331819 isoprenaline increases expression ISO RGD:737538 6480464 Isoproterenol results in increased expression of EDNRA mRNA CTD PMID:20003209 isoprenaline multiple interactions EXP 6480464 CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRA mRNA] more ... CTD PMID:18594475 more ... isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of EDNRA mRNA, Isoproterenol results in increased expression of EDNRA protein CTD PMID:18594475 more ... isoquinoline-1,5-diol decreases expression EXP 6480464 1, 5-dihydroxyisoquinoline results in decreased expression of EDNRA mRNA CTD PMID:12824290 Licochalcone B decreases expression ISO RGD:737537 6480464 licochalcone B results in decreased expression of EDNRA mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO RGD:737537 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide decreases expression ISO RGD:737537 6480464 Lipopolysaccharides results in decreased expression of EDNRA mRNA CTD PMID:35811015 losartan multiple interactions EXP 6480464 Atorvastatin promotes the reaction [Losartan results in decreased expression of EDNRA mRNA], Losartan promotes the reaction [Atorvastatin results in decreased expression of EDNRA mRNA] CTD PMID:23091284 losartan decreases expression EXP 6480464 Losartan results in decreased expression of EDNRA mRNA CTD PMID:23091284 Magnolol multiple interactions EXP 6480464 magnolol inhibits the reaction [Monocrotaline results in increased expression of EDNRA protein] CTD PMID:30466619 methimazole increases expression EXP 6480464 Methimazole results in increased expression of EDNRA mRNA CTD PMID:30047161 methylmercury chloride decreases expression ISO RGD:737537 6480464 methylmercuric chloride results in decreased expression of EDNRA mRNA CTD PMID:28001369 methylseleninic acid increases expression ISO RGD:737537 6480464 methylselenic acid results in increased expression of EDNRA mRNA CTD PMID:18548127 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of EDNRA mRNA CTD PMID:25972201 monocrotaline multiple interactions EXP 6480464 magnolol inhibits the reaction [Monocrotaline results in increased expression of EDNRA protein], Simvastatin inhibits the reaction [Monocrotaline results in increased expression of EDNRA mRNA] CTD PMID:22022327 , PMID:30466619 monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of EDNRA mRNA, Monocrotaline results in increased expression of EDNRA protein CTD PMID:20967148 more ... N(gamma)-nitro-L-arginine methyl ester multiple interactions EXP 6480464 Atrasentan inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of EDNRA mRNA] CTD PMID:34102242 N(gamma)-nitro-L-arginine methyl ester increases expression EXP 6480464 NG-Nitroarginine Methyl Ester results in increased expression of EDNRA mRNA CTD PMID:34102242 nicotine decreases expression ISO RGD:737537 6480464 Nicotine results in decreased expression of EDNRA mRNA CTD PMID:18247414 nitrofen decreases expression ISO RGD:737538 6480464 nitrofen results in decreased expression of EDNRA mRNA CTD PMID:12407540 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of EDNRA mRNA, nitrofen results in increased expression of EDNRA protein CTD PMID:10693666 more ... ouabain increases expression EXP 6480464 Ouabain results in increased expression of EDNRA mRNA, Ouabain results in increased expression of EDNRA protein CTD PMID:15477225 , PMID:16982439 ozone decreases expression EXP 6480464 Ozone results in decreased expression of EDNRA mRNA CTD PMID:16081523 ozone multiple interactions ISO RGD:737538 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of EDNRA mRNA CTD PMID:34911549 ozone multiple interactions EXP 6480464 [Ozone co-treated with Oxygen] inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDNRA mRNA] CTD PMID:26550192 ozone multiple interactions ISO RGD:737537 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EDNRA mRNA more ... CTD PMID:32699268 ozone increases expression EXP 6480464 Ozone results in increased expression of EDNRA mRNA CTD PMID:20980218 panobinostat increases expression ISO RGD:737537 6480464 panobinostat results in increased expression of EDNRA mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:737537 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRA mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:737537 6480464 Acetaminophen results in increased expression of EDNRA mRNA CTD PMID:29067470 paraquat affects expression EXP 6480464 Paraquat affects the expression of EDNRA mRNA CTD PMID:16854511 paraquat decreases expression ISO RGD:737537 6480464 Paraquat results in decreased expression of EDNRA mRNA CTD PMID:35182771 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:737538 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of EDNRA mRNA CTD PMID:36331819 phenylephrine multiple interactions EXP 6480464 [cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] which results in decreased susceptibility to Phenylephrine, phosphoramidon inhibits the reaction [Phenylephrine results in increased expression of EDNRA protein] CTD PMID:15007106 phenylmercury acetate increases expression ISO RGD:737537 6480464 Phenylmercuric Acetate results in increased expression of EDNRA mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737537 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRA mRNA CTD PMID:27188386 phosphoramidon multiple interactions EXP 6480464 phosphoramidon inhibits the reaction [AGT protein results in increased expression of EDNRA protein], phosphoramidon inhibits the reaction [Phenylephrine results in increased expression of EDNRA protein] CTD PMID:15007106 pirinixic acid decreases expression ISO RGD:737538 6480464 pirinixic acid results in decreased expression of EDNRA mRNA CTD PMID:16985257 potassium chloride multiple interactions ISO RGD:737538 6480464 [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] affects the activity of EDNRA protein CTD PMID:18516094 potassium cyanide decreases expression ISO RGD:737538 6480464 Potassium Cyanide results in decreased expression of EDNRA mRNA CTD PMID:33914522 potassium dichromate increases expression ISO RGD:737538 6480464 Potassium Dichromate results in increased expression of EDNRA mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of EDNRA mRNA CTD PMID:30047161 progesterone decreases expression ISO RGD:737537 6480464 Progesterone results in decreased expression of EDNRA mRNA CTD PMID:21795739 Ptaquiloside multiple interactions ISO RGD:737538 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of EDNRA mRNA CTD PMID:23274088 quartz decreases expression ISO RGD:737537 6480464 Quartz results in decreased expression of EDNRA mRNA CTD PMID:27917503 raloxifene multiple interactions ISO RGD:737537 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of EDNRA mRNA, [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of EDNRA mRNA CTD PMID:19059307 reactive oxygen species multiple interactions EXP 6480464 [5-(dimethylamino)-N-(3, 4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide binds to and results in decreased activity of EDNRA protein] inhibits the reaction [Desoxycorticosterone results in increased chemical synthesis of Reactive Oxygen Species] CTD PMID:16271043 rebaudioside A increases expression ISO RGD:737537 6480464 rebaudioside A results in increased expression of EDNRA mRNA CTD PMID:31655124 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Smoke results in increased expression of EDNRA protein], Resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EDNRA protein] CTD PMID:36183783 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:737537 6480464 [S-(1 more ... CTD PMID:35811015 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Smoke results in increased expression of EDNRA protein] CTD PMID:36183783 SB 431542 multiple interactions ISO RGD:737537 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom multiple interactions ISO RGD:737537 6480464 [Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA CTD PMID:19244175 selenium atom decreases expression ISO RGD:737537 6480464 Selenium results in decreased expression of EDNRA mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:737537 6480464 Silicon Dioxide analog results in decreased expression of EDNRA mRNA, Silicon Dioxide results in decreased expression of EDNRA mRNA CTD PMID:25351596 , PMID:25895662 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Cholesterol more ... CTD PMID:19505368 , PMID:22022327 sodium arsenite multiple interactions ISO RGD:737537 6480464 EDNRA protein affects the reaction [sodium arsenite results in decreased expression of PLIN1 protein], sodium arsenite results in decreased expression of and affects the splicing of EDNRA mRNA CTD PMID:23650128 , PMID:25879800 sodium chloride multiple interactions ISO RGD:737538 6480464 [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] affects the activity of EDNRA protein CTD PMID:18516094 sodium chloride multiple interactions EXP 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDNRA mRNA more ... CTD PMID:22431579 , PMID:26550192 steviol increases expression ISO RGD:737537 6480464 steviol results in increased expression of EDNRA mRNA CTD PMID:31655124 stevioside increases expression ISO RGD:737537 6480464 stevioside results in increased expression of EDNRA mRNA CTD PMID:31655124 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of EDNRA mRNA CTD PMID:30047161 sulforaphane decreases expression ISO RGD:737537 6480464 sulforaphane results in decreased expression of EDNRA mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:737537 6480464 Sunitinib results in decreased expression of EDNRA mRNA CTD PMID:31533062 superoxide affects abundance EXP 6480464 EDNRA protein affects the abundance of Superoxides CTD PMID:12600921 tacrolimus hydrate increases activity EXP 6480464 Tacrolimus results in increased activity of EDNRA protein CTD PMID:15964565 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of EDNRA mRNA CTD PMID:8587392 tamoxifen multiple interactions ISO RGD:737537 6480464 [fulvestrant co-treated with Tamoxifen co-treated with ZD4054] results in decreased expression of EDNRA mRNA more ... CTD PMID:19059307 , PMID:19943105 tamoxifen increases expression ISO RGD:737537 6480464 Tamoxifen results in increased expression of EDNRA mRNA CTD PMID:19943105 Tanshinone I multiple interactions EXP 6480464 tanshinone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA protein] CTD PMID:28985491 telmisartan multiple interactions EXP 6480464 telmisartan inhibits the reaction [Daunorubicin results in increased expression of EDNRA protein] CTD PMID:20888384 temozolomide affects response to substance ISO RGD:737537 6480464 EDNRA mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide decreases expression ISO RGD:737537 6480464 Temozolomide results in decreased expression of EDNRA mRNA CTD PMID:31758290 testosterone affects expression EXP 6480464 Testosterone affects the expression of EDNRA mRNA CTD PMID:12122504 , PMID:14616470 testosterone enanthate affects expression ISO RGD:737537 6480464 testosterone enanthate affects the expression of EDNRA mRNA CTD PMID:17440010 tetrachloromethane decreases expression ISO RGD:737538 6480464 Carbon Tetrachloride results in decreased expression of EDNRA mRNA CTD PMID:17484886 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of EDNRA mRNA CTD PMID:34492290 titanium dioxide affects expression ISO RGD:737538 6480464 titanium dioxide affects the expression of EDNRA mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:737538 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EDNRA mRNA CTD PMID:29950665 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of EDNRA gene CTD PMID:27618143 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of EDNRA mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:737537 6480464 trichostatin A results in increased expression of EDNRA mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:737537 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRA mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:737537 6480464 Triclosan results in decreased expression of EDNRA mRNA CTD PMID:30510588 valproic acid decreases expression ISO RGD:737537 6480464 Valproic Acid results in decreased expression of EDNRA mRNA CTD PMID:23179753 , PMID:28001369 valproic acid multiple interactions ISO RGD:737537 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRA mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:737537 6480464 Valproic Acid results in increased expression of EDNRA mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:737538 6480464 Valproic Acid results in increased expression of EDNRA mRNA CTD PMID:24896083 valproic acid affects expression ISO RGD:737537 6480464 Valproic Acid affects the expression of EDNRA mRNA CTD PMID:25979313 valsartan decreases expression EXP 6480464 Valsartan results in decreased expression of EDNRA mRNA CTD PMID:28951255 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of EDNRA mRNA CTD PMID:20566332 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of EDNRA mRNA CTD PMID:19015723 vitamin E multiple interactions ISO RGD:737537 6480464 [Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA CTD PMID:19244175 vitamin E decreases expression ISO RGD:737537 6480464 Vitamin E results in decreased expression of EDNRA mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:737537 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRA mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:737537 6480464 vorinostat results in increased expression of EDNRA mRNA CTD PMID:26272509